Dosing and frequency may be adjusted based on your prescribed plan, response, and tolerability
Recovery Planning Provider-guided discussion around recovery planning as part of your personalized care plan
Description BPC-157 Body Protective Compound for Research Overview: BPC-157 is a synthetic analog currently being studied for its regenerative support properties in experimental settings
facilities and every step of our peptide manufacturing process is conducted right here in the USA with full documented supply chain control end to end

Conclusion: The results obtained with the creation of the EsPIO scale show very high negative predictive values that are comparable to other scales validated in other studies to detect LVO Disclosure of interest: No disclosures E-Posters - PRE-HOSPITAL SERVICE ORGANISATION 09.00 - PRE-HOSPITAL SERVICE ORGANISATION - 09.01 - PRE-HOSPITAL SERVICE ORGANISATION P2627 - ESOC25-2430 ABOARD THE MOTHERSHIP: EARLY CLINICAL EXPERIENCE WITH DIRECT TO THROMBECTOMY PATHWAY Chak Lam Ip 1 , Jonathan Hayton 2 , Selina Edwards 1 , Sohaa Jamil 2 , Ken Crossley 3 , Rajaram Bathula 2 , Soma Banerjee 2 , Rob Simister 1 1 University College London Hospitals NHS Foundation Trust, London, United Kingdom, 2 Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom, 3 London Ambulance Service NHS Trust, London, United Kingdom Background and Aims: In London, suspected strokes are directed to the nearest hyperacute stroke unit (HASU), but not all offer mechanical thrombectomy